1. Japan Stocks

  2. •

    Distribution services

  3. •

    Medical distributors
J Frontier Co., Ltd.

J Frontier Co., Ltd.

TTSE:2934
1,940.00
JPY
+9.00
(+0.47%)
8.39BMarket Cap
Jan 08Next Earn
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
1,335.47
1,549.19
1,851.54
2,687.88
3,640.32
3,617.51
4,277.82
4,166.99
- -
Basic EPS, GAAP
1.34
21.01
92.64
90.64
-410.6
-429.05
17.42
-60.21
- -
Free Cash Flow per Basic Share
-7.27
46.47
179.64
-85.41
-418.19
-315.43
88.96
72.22
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
162.53
183.73
276.37
907.63
527.94
229.89
269.38
230.22
269.38
Tangible Book Value per Share
159.6
174.99
272.28
703.8
114.19
-485.54
-268.84
-258.43
-268.84
Basic Weighted Avg Shares
5
5
5
4
5
5
5
5
5
Sales/Revenue/Turnover
6,126
7,106
8,493
11,877
16,845
17,715
21,504
22,236
- -
Operating Margin (%)
6.01
2.4
7.91
6.16
-10.78
-3.42
1.37
1.4
- -
Depreciation Expense
7
101
26
59
294
460
264
369
- -
Net Income, GAAP
6
96
425
401
-1,900
-2,101
88
-321
- -
Effective Tax Rate (%)
94.5
28.61
37.41
42.85
- -
- -
46.93
- -
- -
Profit Margin (%)
0.1
1.36
5
3.37
-11.28
-11.86
0.41
-1.45
- -
Working Capital
812
749
1,089
3,478
1,652
1,205
892
393
892
LT Debt
169
75
8
460
1,384
2,893
1,969
2,034
1,969
Total Equity
746
843
1,268
4,164
2,715
1,880
2,014
1,534
2,014
Return on Invested Capital (%)
- -
11.52
31.42
12.73
- -
- -
2.23
- -
- -
Return on Capital (%)
- -
9.61
36.14
13.27
- -
- -
1.12
- -
- -
Return on Common Equity (%)
- -
12.14
40.27
14.82
-57.45
-116.19
6.88
-24.39
- -

Capital Structure

JPY

•

in mil. unless spec.
Aug'25
Nov'25
May'25
ST Debt
- -
2,516
2,374
LT Borrowings
- -
2,419
1,955
LT Finance Leases
- -
- -
14
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
5
5
5
Market Capitalization
7,822
9,000
8,389

Working Capital

JPY

•

in mil. unless spec.
Aug'25
Nov'25
May'25
Total Current Assets
- -
5,953
5,655
Cash, Cash Equivalents & STI
- -
1,881
2,170
Accounts Receivable, Net
- -
1,572
1,248
Inventories
- -
2,164
1,837
Total Current Liabilities
- -
4,966
4,763
Payables & Accruals
- -
- -
- -
ST Debt
- -
2,516
2,374
Deferred Revenue
- -
- -
- -

Growth Rates

JPY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
29.24%
-23.84%
Free Cash Flow
- -
20.8%
-13.83%
Net Income, GAAP
- -
-228.12%
-466.92%
Sales/Revenue/Turnover
- -
22.33%
3.4%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
4,224
3,790
4,870
4,831
17,715
2025
- -
- -
- -
- -
21,504
2026
- -
- -
- -
- -
22,236

Quarterly Earnings Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-6.64
-51.91
-25.95
-337.28
-429.05
2025
- -
- -
- -
- -
17.42
2026
- -
- -
- -
- -
-60.21

Quarterly Dividends Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Atsuhiro Nakamura
Full Time Employees
201
Sector
Distribution services
Industry
Medical distributors
Address
9-8 Sakuragaokacho Tokyo Japan 150-0031
IPO Date
Aug 27, 2021
Website
jfrontier.jp
Similar Companies
DataMeds AI, Inc. (NASDAQ:MEDS)
Selcuk Ecza Deposu Ticaret ve Sanayi A.S. (BIST:SELEC)
McKesson Corporation (NYSE:MCK)
Ibnsina Pharma (EGX:ISPH)
Cardinal Health, Inc. (NYSE:CAH)
Entero Healthcare Solutions Limited (NSE:ENTERO)
Business
J Frontier Co., Ltd. (TSE:2934) operates as a Japan-based healthcare technology company primarily engaged in medical care sales, healthcare sales, and healthcare marketing businesses. Founded in 2008 and headquartered at KN Shibuya 3, 4th Floor, 9-8 Sakuragaokacho, Shibuya-ku, Tokyo, the company provides e-commerce sales of healthcare-related products and pharmaceuticals; online medication guidance and drug delivery via its proprietary platform SOKUYAKU; operation of dispensing pharmacies and mail-order services for ethical drugs including the Why Pure series and Chinese herbs; planning, development, and direct-to-consumer sales of health foods and cosmetics such as the 328 selection series of fermented hydrogen, FAVEUR skincare including the 2025 Christmas coffer limited release, and SOKUYAKU Beauty whitening products; internet advertising agency services for healthcare products; sales promotion support; and wholesale of in-house products, with all operations concentrated in Japan targeting consumers, clinics, pharmacies, and healthcare firms. The Medical Care Sales segment centers on SOKUYAKU's online clinic integration, same-day delivery, and pharmacy partnerships; Healthcare Sales focuses on original branded supplements, smoothies like the top-ranked Completely Drink Hydrogen 328 Fresh Picked Green Smoothie, and beauty items; while Healthcare Marketing delivers promotional campaigns leveraging talent endorsements. Recent developments include ongoing SOKUYAKU alliance expansions with multiple partners such as Pharmarise Holdings integrating the app across 302 group pharmacies in October 2024, Usagi Pharmacy and Ichigo Pharmacy in November 2025, Miyazaki Zenikai Hospital, and a partnership with table tennis T-League team Shizuoka Jade in December 2025; product launches like the FAVEUR Christmas coffer on November 20, 2025, and premium shareholder benefits renewal announcement on November 21, 2025; certification as an excellent healthy company in gold tier; and release of an ID collaboration API for external systems.